BICO Group Past Earnings Performance

Past criteria checks 0/6

BICO Group's earnings have been declining at an average annual rate of -81.8%, while the Life Sciences industry saw earnings growing at 30.7% annually. Revenues have been growing at an average rate of 53.7% per year.

Key information

-81.8%

Earnings growth rate

-77.9%

EPS growth rate

Life Sciences Industry Growth	31.8%
Revenue growth rate	53.7%
Return on equity	-34.6%
Net Margin	-70.6%
Next Earnings Update	07 May 2024

Recent past performance updates

Recent updates

Here's Why BICO Group (STO:BICO) Can Afford Some Debt

Jul 01

The Market Doesn't Like What It Sees From BICO Group AB (publ)'s (STO:BICO) Earnings Yet As Shares Tumble 26%

Jun 08

Bullish: This Analyst Just Lifted Their Cellink AB (publ) (STO:CLNK B) Outlook For Next Year

Jul 22

Does Cellink (STO:CLNK B) Have A Healthy Balance Sheet?

Jun 24

Does Cellink (STO:CLNK B) Have A Healthy Balance Sheet?

Mar 07

Revenue & Expenses Breakdown
Beta

How BICO Group makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OM:BICO Revenue, expenses and earnings (SEK Millions)
Date	Revenue	Earnings	G+A Expenses
31 Dec 23	2,405	-1,697	1,537
30 Sep 23	2,459	-1,986	1,773
30 Jun 23	2,464	-1,849	1,884
31 Mar 23	2,483	-907	1,961
31 Dec 22	2,327	-85	1,818
30 Sep 22	2,278	41	1,857
30 Jun 22	1,995	-130	1,666
31 Mar 22	1,743	-224	1,354
31 Dec 21	1,378	-228	1,061
30 Sep 21	993	-188	749
30 Jun 21	744	-96	519
31 Mar 21	460	-50	342
31 Dec 20	369	-36	273
31 Aug 20	236	-62	218
31 May 20	213	-49	197
29 Feb 20	197	-24	176
30 Nov 19	173	-5	138
31 Aug 19	135	1	106
31 May 19	118	3	87
28 Feb 19	97	4	69
30 Nov 18	76	2	55
31 Aug 18	61	1	43
31 May 18	45	1	30
28 Feb 18	34	-2	24
30 Nov 17	27	-2	21
31 Aug 17	20	-1	16
31 Aug 16	6	-1	4

Quality Earnings: BICO is currently unprofitable.

Growing Profit Margin: BICO is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: BICO is unprofitable, and losses have increased over the past 5 years at a rate of 81.8% per year.

Accelerating Growth: Unable to compare BICO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BICO is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (46.4%).

Return on Equity

High ROE: BICO has a negative Return on Equity (-34.6%), as it is currently unprofitable.

BICO Group Past Earnings Performance

Past criteria checks 0/6

Key information

Recent past performance updates

BICO Group AB (publ) to Report Fiscal Year 2024 Results on Feb 19, 2025

BICO Group AB (publ) to Report Q3, 2024 Results on Nov 13, 2024

Full year 2023 earnings released: kr24.05 loss per share (vs kr12.94 loss in FY 2022)

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Mar 15, 2024

Second quarter 2023 earnings released: kr12.73 loss per share (vs kr0.68 profit in 2Q 2022)

First quarter 2023 earnings released: kr1.67 loss per share (vs kr0.68 loss in 1Q 2022)

Recent updates

BICO Group AB (publ) Announces the Appointment of Anders Fogelberg as Chief Commercial Officer, Effective June 13, 2024

BICO Group AB (publ) Announces Gerry Mackay and Erik Gatenholm Decline Re-Election of the Board of Directors

BICO Group AB (publ) to Report Fiscal Year 2024 Results on Feb 19, 2025

BICO Group AB (publ) to Report Q3, 2024 Results on Nov 13, 2024

Full year 2023 earnings released: kr24.05 loss per share (vs kr12.94 loss in FY 2022)

New major risk - Financial position

BICO Group AB (publ) Appoints Catharina Nordlund as Global Head of HR

Group Chief Financial Officer recently bought kr860k worth of stock

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Mar 15, 2024

New minor risk - Share price stability

Price target decreased by 8.1% to kr130

Second quarter 2023 earnings released: kr12.73 loss per share (vs kr0.68 profit in 2Q 2022)

BICO Group AB (publ) Announces Chief Executive Officer Changes

Beos Light Industrial Germany 1 Fund, a fund managed by BEOS AG agreed to acquire property on Wagner-Régeny-Straße 15 from BICO Group AB (publ) (OM:BICO) for €21 million.

Here's Why BICO Group (STO:BICO) Can Afford Some Debt

The Market Doesn't Like What It Sees From BICO Group AB (publ)'s (STO:BICO) Earnings Yet As Shares Tumble 26%

Independent Deputy Chairwoman recently bought kr59k worth of stock

BICO Group AB (publ) Elects Gerry Mackay to Its Board of Directors

First quarter 2023 earnings released: kr1.67 loss per share (vs kr0.68 loss in 1Q 2022)

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 20, 2024

Price target decreased by 8.0% to kr133

Independent Director recently bought kr100k worth of stock

Now 38% undervalued after recent price drop

Independent Chairman of the Board recently sold kr8.4m worth of stock

BICO Group AB Appoints Marius Balger as Chief Operating Officer, Effective March 1, 2023

BICO Group AB Announces the Appointment of Jacob Thordenberg as Group CFO

Price target increased to kr144

Consensus EPS estimates increase by 14%

Why BICO Group AB (publ) (STO:BICO) Could Be Worth Watching

Price target decreased to kr124

BICO Group AB (publ) to Report Q1, 2023 Results on May 04, 2023

Consensus EPS estimates increase by 101%

Now 29% undervalued

Price target decreased to kr150

High number of new and inexperienced directors

Third quarter 2022 earnings released

BICO Group AB (publ) to Report Q2, 2023 Results on Jul 20, 2023

BICO Group Announces Appointment of Nomination Committee 2023

Forecast breakeven date moved forward to 2022

Second quarter 2022 earnings released

Forecast breakeven date moved forward to 2022

Now 21% undervalued after recent price drop

Independent Director recently bought kr102k worth of stock

Calculating The Fair Value Of BICO Group AB (publ) (STO:BICO)

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 22, 2023

BICO Group Adds Åsa Hillsten as SVP and Head of IR

BICO Group AB (publ) (OM : BICO) acquired Allegro 3D for $11 million.

Is BICO Group AB (publ) (STO:BICO) Potentially Undervalued?

Now 22% undervalued after recent price drop

BICO (publ) Appoints Mikael Engblom as Interim CFO

Price target decreased to kr350

High number of new and inexperienced directors

BICO Group AB (Publ) Announces Board Appointments

Price target decreased to kr350

Co-Founder recently bought kr1.0m worth of stock

Full year 2021 earnings: EPS and revenues exceed analyst expectations

BICO Reaches Beneficial and Sustainable Solution with Organovo

Is BICO Group (STO:BICO) Using Too Much Debt?

DISPENDIX, A BICO Company, Announces That the I.DOT HT Non-contact Dispenser and the L.DROP Liquid Handler will be introduced at SLAS 2022

BICO Group AB Announces Statement Regarding Counterclaims in Patent Lawsuit by Organovo Against Cellink

Chief Financial Officer exercised options to buy kr23m worth of stock.

Co-Founder recently bought kr20m worth of stock

BICO Group AB (publ) (OM:BICO) agreed to acquire Biosero Llc.

Third quarter 2021 earnings released

Price target decreased to kr545

Health Check: How Prudently Does BICO Group (STO:BICO) Use Debt?

Insider recently sold kr11m worth of stock

BICO Group AB (publ) (OM:BICO) acquired all outstanding shares in Advanced BioMatrix, Inc. for $18 million.

CEO & Director recently sold kr169m worth of stock

Revenue & Expenses Breakdown
Beta